SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001293971-22-000002
Filing Date
2022-01-11
Accepted
2022-01-11 07:04:09
Documents
13
Period of Report
2022-01-11
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K blue-20220111.htm   iXBRL 8-K 36309
2 EX-99.1 exhibit99120220111.htm EX-99.1 13629
  Complete submission text file 0001293971-22-000002.txt   192088

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blue-20220111.xsd EX-101.SCH 1923
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT blue-20220111_lab.xml EX-101.LAB 24270
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT blue-20220111_pre.xml EX-101.PRE 12652
7 EXTRACTED XBRL INSTANCE DOCUMENT blue-20220111_htm.xml XML 11260
Mailing Address 60 BINNEY STREET CAMBRIDGE MA 02142
Business Address 60 BINNEY STREET CAMBRIDGE MA 02142 339-499-9300
bluebird bio, Inc. (Filer) CIK: 0001293971 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35966 | Film No.: 22522730
SIC: 2836 Biological Products, (No Diagnostic Substances)